FDA

Biogen gears up Swiss manufacturing facility for potential aducanumab rollout
Biogen gears up Swiss manufacturing facility for potential aducanumab rollout
Fierce Pharma
Biogen
Alzheimer's disease
aducanumab
FDA
drug manufacturing
Flag link:
From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now
From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now
Motley Fool
FDA
drug approvals
Gilead Sciences
remdesivir
AstraZeneca
Merck
Lynparza
Clovis Oncology
Rubraca
Bristol-Myers Squibb
Opdivo
Yervoy
Flag link:
Novartis Drug Wins FDA Approval for Lung Cancers With Specific Mutation
Novartis Drug Wins FDA Approval for Lung Cancers With Specific Mutation
Xconomy
Novartis
Tabectra
FDA
non-small cell lung cancer
capmatinib
Flag link:
Fresenius Kabi recalls anti-inflammation drug Ketorolac after finding particles in vials
Fresenius Kabi recalls anti-inflammation drug Ketorolac after finding particles in vials
Fierce Pharma
Fresenius Kabi
Ketorolac
FDA
product recalls
Flag link:
Another delay for Bristol Myers cell therapy as FDA extends review
Another delay for Bristol Myers cell therapy as FDA extends review
BioPharma Dive
FDA
Bristol-Myers Squibb
liso-cell
cancer
cell therapy
Flag link:
Will a Migraine Drug Save This Debt-Ridden Giant?
Will a Migraine Drug Save This Debt-Ridden Giant?
Motley Fool
Teva Pharmaceutical
Ajovy
FDA
migraines
Flag link:
FDA tightens oversight of antibody tests for COVID-19
FDA tightens oversight of antibody tests for COVID-19
RAPS.org
FDA
antibodies
pandemic
COVID-19
diagnostics
Flag link:
FDA accepts for priority review Bristol Myers Squibb’s application for CC-486 for maintenance treatment of adults in remission with AML
FDA accepts for priority review Bristol Myers Squibb’s application for CC-486 for maintenance treatment of adults in remission with AML
Pharmaceutical Business Review
Bristol-Meyers Squibb
FDA
CC-486
AML
acute myeloid leukemia
Flag link:
FDA Grants Emergency Authorization To Roche Antibody Tests
FDA Grants Emergency Authorization To Roche Antibody Tests
Forbes
Roche
FDA
antibodies
diagnostics
Emergency Use Authorization
Flag link:
J&J defends Darzalex with FDA approval for faster dosing
J&J defends Darzalex with FDA approval for faster dosing
Pharmaforum
JNJ
FDA
Darzalex
dosing
Multiple Myeloma
Flag link:
FDA Authorizes Gilead's Remdesivir for COVID-19
FDA Authorizes Gilead's Remdesivir for COVID-19
Motley Fool
Gilead Sciences
FDA
COVID-19
remdesivir
Emergency Use Authorization
Flag link:
Indian pharmas call on FDA to perform 'virtual' facility checks during COVID-19 inspection lockdown
Indian pharmas call on FDA to perform 'virtual' facility checks during COVID-19 inspection lockdown
Fierce Pharma
India
COVID-19
drug manufacturing
FDA
Flag link:
FDA creates umbrella emergency pathway for COVID-19 serology tests
FDA creates umbrella emergency pathway for COVID-19 serology tests
RAPS.org
FDA
diagnostics
serology tests
Emergency Use Authorization
COVID-19
pandemic
Flag link:
Go or no go? Oncology dominates upcoming decisions
Go or no go? Oncology dominates upcoming decisions
EP Vantage
FDA
oncology
AstraZeneca
Lynparza
ovarian cancer
prostate cancer
Bristol-Myers Squibb
Opdivo
lung cancer
Flag link:
Has Biogen Found the Answer to Treating Alzheimer's?
Has Biogen Found the Answer to Treating Alzheimer's?
Motley Fool
Biogen
FDA
Alzheimer's disease
aducanumab
Flag link:
After NIH trial, EMA begins rolling review for remdesivir, setting up potential authorizations in US and Europe
After NIH trial, EMA begins rolling review for remdesivir, setting up potential authorizations in US and Europe
Endpoints
Gilead Sciences
remdesivir
COVID-19
EMA
NIH
FDA
Europe
Flag link:
FDA lifts drug supply chain security requirements for COVID-19 products
FDA lifts drug supply chain security requirements for COVID-19 products
RAPS.org
FDA
COVID-19
supply chain
Drug Supply Chain Security Act
Flag link:
There May Be a New First-Line Treatment for Depression
There May Be a New First-Line Treatment for Depression
Motley Fool
Axsome Therapeutics
FDA
depression
AXS-05
Flag link:
Pfizer looks to right sterile injectable woes with modernized manufacturing
Pfizer looks to right sterile injectable woes with modernized manufacturing
Fierce Pharma
Pfizer
FDA
injectibles
drug manufacturing
Flag link:
Pear rolls out digital therapy for schizophrenia under FDA’s COVID-19 scheme
Pear rolls out digital therapy for schizophrenia under FDA’s COVID-19 scheme
Pharmaforum
Pear Therapeutics
digital therapeutics
schizophrenia
FDA
COVID-19
pandemic
Flag link:

Pages